bilxona 30mg modified-release tablets
actavis group ptc ehf - gliclazide - modified-release tablet - 30mg - a10bb09 - non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose
vamju 30mg modified-release tablets
mercury pharmaceuticals limited - gliclazide - modified-release tablet - 30mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
vamju 60mg modified-release tablets
mercury pharmaceuticals limited - gliclazide - modified-release tablet - 60mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
vamju 30mg modified-release tablets
advanz pharma - gliclazide - modified-release tablet - 30mg
vamju 60mg modified-release tablets
advanz pharma - gliclazide - modified-release tablet - 60mg
diadeon mr 60 mg modified release tablets 60 milligram modified-release tablets
les laboratoires servier - gliclazide - modified-release tablets - 60 milligram
none 60 mg modified release tablet modified release tablet
n/a; importer: ambica international corporation; distributor: tgp pharma inc. - gliclazide - modified release tablet - 60 mg modified release tablet
gliclazide mr 30 mg prolonged-release tablets
bristol laboratories limited - gliclazide - prolonged-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide
gliclazide mr 30 mg prolonged-release tablets
brillpharma (ireland) limited - gliclazide - prolonged-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide
diamicron mr tablets 60
les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - gliclazide - modified-release tablet - gliclazide - drugs used in diabetes